Indication

GLP-1 medications for Chronic kidney disease in type 2 diabetes

GLP-1 medications for Chronic kidney disease in type 2 diabetes, with sourced prices, shortage reports and study results.

Last checked · Oct 3, 2026 UTC

1approved

Approved for this use

Alphabetical by active ingredient. Approved uses depend on the specific brand and formulation.

GLP-1

Semaglutide

Ozempic, Wegovy, Wegovy HD, Rybelsus

Subcutaneous injection (Ozempic, Wegovy); oral tablet (Rybelsus, oral Ozempic, Wegovy pill) · Once weekly (injectable); once daily (oral)

FDA shortage report

Published entry quote

$149-$299/mo

Wegovy pill (oral semaglutide) via GoodRx · GoodRx

Checked Sep 30, 2026

Price conditions

by dose; Novo Nordisk's self-pay price through a GoodRx coupon

The same oral semaglutide and prices as the NovoCare offer: $149 (1.5 mg), $199 (4 mg), $299 (9 mg and 25 mg), per Novo Nordisk's published self-pay ladder. FDA-approved product.

30-day supply

Third-party reported price.

Checked Sep 30, 2026. Entry quotes are not estimates of ongoing treatment cost.

Prices, evidence & safety

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.